Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Open accessPublished version of a preprint
The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index; 17 of the 28 sources its claims cite were checked for support.
Abstract
Abstract Ageing is the biggest risk factor for cardiovascular disease. Cellular senescence, a process driven in part by telomere shortening, has been implicated in age‐related tissue dysfunction. Here, we address the question of how senescence is induced in rarely dividing/post‐mitotic cardiomyocytes and investigate whether clearance of senescent cells attenuates age‐related cardiac dysfunction. During ageing, human and murine cardiomyocytes acquire a senescent‐like phenotype characterised by persistent DNA damage at telomere regions that can be driven by mitochondrial dysfunction and crucially can occur independently of cell division and telomere length. Length‐independent telomere damage in cardiomyocytes activates the classical senescence‐inducing pathways, p21 CIP and p16 INK4a , and results in a non‐canonical senescence‐associated secretory phenotype, which is pro‐fibrotic and pro‐hypertrophic. Pharmacological or genetic clearance of senescent cells in mice alleviates detrimental features of cardiac ageing, including myocardial hypertrophy and fibrosis. Our data describe a mechanism by which senescence can occur and contribute to age‐related myocardial dysfunction and in the wider setting to ageing in post‐mitotic tissues.
Overview
CoChat Summary
## TL;DR
The paper argues that ageing cardiomyocytes acquire a senescent-like state through persistent telomere-associated DNA damage that is independent of telomere shortening, cell division, and telomerase activity. Clearing senescent cells in mice reduced cardiomyocyte hypertrophy and fibrosis, suggesting a therapeutic angle for age-related cardiac dysfunction.
## Key findings
- In mouse and human hearts, mean telomere-associated foci (TAF) per cardiomyocyte and the percentage of cardiomyocytes with TAF increased significantly with age, while total γH2A.X foci did not change with age.
- In purified cardiomyocytes from young (3 months) vs old (20 months) mice, RNA-seq found 416 differentially expressed genes; principal component analysis separated the groups with the first two components explaining 80.1% and 7.8% of variance.
- Aged cardiomyocytes upregulated senescence markers and hypertrophy-related genes: p16Ink4a, p21CIP, and p15Ink4b increased, and hypertrophy genes including Myh7 and Acta1 increased, but canonical SASP genes such as Il-1α, Il-1β, Il-6, Cxcl1, and Cxcl2 were not differentially expressed.
- Senescent-cell clearance improved cardiac structure: in aged INK-ATTAC mice, AP treatment reduced p16Ink4a- and eGFP-positive cells, reduced TAF in cardiomyocytes, reduced average cardiomyocyte cross-sectional area, and decreased fibrosis; navitoclax likewise significantly reduced hypertrophy and fibrosis in aged wild-type mice.
- Navitoclax increased evidence of cardiomyocyte renewal: EdU-labelled cardiomyocytes increased from 0.07% in vehicle controls to 0.23% with navitoclax.
## Methods
- The study combined in vivo ageing and intervention experiments in mice with human heart tissue from patients undergoing open-heart surgery for aortic stenosis, plus multiple cell culture systems (rat neonatal cardiomyocytes, mouse embryonic cardiomyocytes, H9C2 myoblasts, and AC10 cells).
- Telomere damage was assessed mainly by dual immuno-FISH for DDR proteins (γH2A.X, 53BP1) co-localised with telomeres, along with STED microscopy, ChIP-qPCR for γH2A.X at telomeres, SA-β-Gal staining, RNA-seq, and cytokine assays.
- Causality was tested using telomere-targeted damage (TRF1-FokI), oxidative stress/mitochondrial dysfunction models, and senescent-cell clearance via INK-ATTAC/AP20187 and the senolytic navitoclax (ABT263).
## Limitations
- The paper states that interphase telomere FISH does not identify telomeres on specific chromosomes or detect telomere-free ends; it also notes that with 3-μm tissue sections, the entirety of cardiomyocyte nuclei may not be captured.
- The authors note that although STED improved resolution, clusters of telomeres may still not be fully resolved.
- Evident from the text: several mechanistic links are correlative rather than definitively causal in vivo, and the authors explicitly say it remains possible that mitochondrial dysfunction is a consequence, rather than the cause, of telomere dysfunction.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
12 Valid · 0 Not valid · 8 Not checked · 110 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Work by us and others previously demonstrated demonstrated that stress exposure leads to activation of a persistent DDR at telomeric regions”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Telomere damage is persistent in cardiomyocytes
What the sources say
- Supportedcites Fumagalli et al, 2012 matched to “Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation” (2012) source
The Results section on DDR markers during physiological ageing states that exposure to exogenous or endogenous DNA damage can produce breaks at telomeres that remain unrepaired, resulting in persistent DDR foci. This supports the claim when stress exposure refers to DNA-damaging stress. (LLM, conf=0.93)
- Supportedcites Hewitt et al, 2012 matched to “Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence” (2012) source
The paper reports that DNA damage foci induced by exogenous stress are preferentially located at telomeres and that persistent foci are associated with telomeres (Abstract). The Results section, “TAF are persistent in stress-induced senescence,” also reports enrichment of the DDR marker γH2A.X at telomere repeats 10 days after irradiation. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Coppé et al, 2008 matched to “Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor” (2008) source
The citation supports the description of these as pro-inflammatory SASP-associated genes, not the citing authors’ finding about young and aged cardiomyocytes. The paper describes inflammatory cytokines and chemokines as SASP components, including IL-6, and identifies IL-1α and IL-1β as SASP factors; the cardiomyocyte comparison is not attributed to it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS)”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Swanson et al, 2013 matched to “Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence” (2013) source
The Results section (‘Marked distension of satellite DNA in a subset of primary human fibroblasts’; page unavailable) identifies distended centromeric satellite signals using DNA hybridization. The section on senescent murine cells likewise reports distended centromeric signals and calls this change SADS. The age-dependent cardiomyocyte finding is explicitly the citing authors’ own observation (‘we also observed’), not a finding attributed to this source. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In mouse models of accelerated telomere shortening, critically short telomeres have been shown to repress PGC1‐α‐ and β‐mediated mitochondrial biogenesis (Sahin et al, 2011; Chang et al, 2016).”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Supportedcites Sahin et al, 2011 matched to “Telomere dysfunction induces metabolic and mitochondrial compromise” (2011) source
The section “Telomere dysfunction represses PGC network and mitochondrial biogenesis” describes successive generations of telomerase-deficient mice with decreasing telomere reserves and reports reduced PGC-1α and PGC-1β expression in mice with severe telomere dysfunction. The Discussion states that these analyses established a link between telomere dysfunction and repression of PGC-dependent mitochondrial biogenesis. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Supportedcites Chang et al, 2016 matched to “Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy” (2016) source
The Results (Fig. 3 legend, p. —) state 'Critically short telomeres lead to activation of p53, leading to decreased mitochondrial biogenesis' with reduced Pgc1α and Pgc1β transcripts, and the Results text concludes that 'critically shortened telomeres in dystrophin-deficient cardiomyocytes in conjunction with a DNA damage response block mitochondrial biogenesis.' The Discussion additionally describes the TERT G4 null mouse model of ubiquitous telomere shortening developing mitochondrial dysfunction 'because of p53-dependent inhibition of PGC1α/β,' and the Significance section summarizes reduced mitochondrial biogenesis via p53 activation in the humanized-telomere mdx4cv/mTR model. Thus the mouse-model attribution of short-telomere repression of PGC1α/β-mediated mitochondrial biogenesis is stated in our copy. (LLM, conf=0.90)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our study, in accordance with others (Baker et al, 2016; Roos et al, 2016; Demaria et al, 2017), shows that the loss of senescent cardiomyocytes does not adversely alter cardiac function in aged mice.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Partly supportedcites Baker et al, 2016 matched to “Naturally occurring p16Ink4a-positive cells shorten healthy lifespan” (2016) sourceExperimental — accuracy not yet measured
The section “p16Ink4a-positive cells contribute to cardiac aging” (page not provided) reports no significant difference in resting echocardiographic measures between treated and untreated 18-month-old mice, and preserved cardiac stress tolerance after treatment. But the paper describes clearance of p16Ink4a-positive cells, not specifically the loss of senescent cardiomyocytes; the identified senescence-marker-positive cardiac cells include pericardial epithelial cells and fibroblasts and aortic-root smooth muscle cells. (LLM, conf=0.88)
- Could not verifycites Roos et al, 2016 matched to “Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice” (2016) sourceExperimental — accuracy not yet measured
The age-related vascular pathology section reports clearance of senescent cells from the aortic vessel wall and improved carotid artery relaxation in aged mice. The copy does not report loss of senescent cardiomyocytes or assess whether their loss adversely affects cardiac function (searched: cardiomyocytes, cardiac function, heart function, echocardiography). (LLM, conf=0.74)
- Partly supportedcites Demaria et al, 2017 matched to “Cellular senescence promotes adverse effects of chemotherapy and cancer relapse” (2017) sourceExperimental — accuracy not yet measured
In Results (“Inflammation, bone marrow recovery and heart function”; page unavailable), eliminating senescent cells after doxorubicin treatment almost completely prevented declines in cardiac function. But the paper says those cardiac senescent cells were primarily endothelial cells and fibroblast-like cells, not cardiomyocytes. It therefore does not establish that loss of senescent cardiomyocytes is harmless in aged mice. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims
Create a free account to see all 130 claims and to verify the 4 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 46
- The quote only partly states this claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“genetic and pharmacological clearance of p16-expressing senescent cells ameliorated heart functions in aged mice140.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [140]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice, despite having long telomeres and ubiquitous telomerase expression, show an age-dependent increase in dysfunctional telomeres in both proliferating and non-proliferating tissues20,34–37.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the levels of DDR markers and TAFs increase during ageing in different mammalian tissues.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The clearance of senescent cells in aged mice improves heart functions and reduces the fraction of TAF-positive cardiomyocytes without a significant effect on mean telomere length36.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clearance of senescent cells in aged mice and in mice with atherosclerosis using genetic and pharmacological approaches improves vascular and myocardial function and attenuates age-dependent remodelling.25,27”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [27]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Hearts from mixed‐sex CJ57/BL6 mice were placed on a Langendorff setup.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Mixed‐sex C57BL/6 mice were analysed at either 3, 15, 20, 24 or 30 months of age.”
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Senescence-associated b -galactosidase activity assay SA-b -Gal activity assay was performed as described previously (Dimri et al , 1995).”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · cited 1×
“Telomere shortening has been proposed as a major inducer of senescence (Bodnar et al , 1998).”
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationHucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060 · cited 1×
“The models were encoded in the Systems Biology Markup Language (SBML) modelling standard (Hucka et al , 2003) with the Python SBML shorthand tool (Wilkinson, 2011).”
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“…associated with a protein complex known as shelterin (de Lange, 2005), which facilitates the formation of a lariat-like structure to shield the exposed end of DNA (Griffith et al , 1999), thus protecting the ends of chromosomes from being recognised as DNA damage (d’Adda di Fagagna et al , 2003).”
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 3×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“Furthermore, we found a significant increase in TAF in CMs from Polg mut/mut mice, a model of accelerated ageing due to mitochondrial dysfunction (Trifunovic et al , 2004; Fig 6G).”
Cited by
Items 401–500 of 523
Teng, Y., Bian, W., Li, Q., Eyk, J. E. V., Yan, X., & Zhang, S. Y. (2026) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2026-0043 · Cited by 4
“[86]”
In the heart of cardiac stromal senescence
Douin‐Echinard, V., Lefèvre, L., & Parini, A. (2020) · Aging · doi:10.18632/aging.102806 · Cited by 2
Self-citationCellular senescence during aging and chronic liver diseases
Jurk, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00005-5 · Cited by 2
Self-citationThe Length of Leukocyte and Femoral Artery Telomeres in Patients with Peripheral Atherosclerosis
Boniewska‐Bernacka, E., Pańczyszyn, A., Hobot, J., Donizy, P., Ziembik, Z., Goc, A., & Klinger, M. (2022) · Genes · doi:10.3390/genes13040704 · Cited by 2
“This phenomenon is independent of cell proliferation and telomere length [23].”
BackgroundBibliometric analysis of trends in cardiac aging research over the past 20 years
Hao, Y., Li, B., Huber, S. A., & Liu, W. (2023) · Medicine · doi:10.1097/md.0000000000034870 · Cited by 2
“Telomeres are susceptible to oxidative stress,[24] and Anderson et al[25] demonstrated that telomere damage causes cardiomyocyte senescence.”
BackgroundFaingold, I. I., Smolina, A. V., Soldatova, Y. V., Poletaeva, D. A., Балакина, А. А., Sashenkova, T. E., Allayarova, U. Y., Prikhodchenko, T. R., Blokhina, S. V., Makartseva, L. A., et al. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01203-7 · Cited by 2
“Inter-estingly, R. Anderson et al. [36] showed that MAO-A-induced mitochondrial ROS cause telomere damage in cardiomyocytes.”
Torrance, J. B., & Goldband, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217959 · Cited by 2
Role of biological markers in stem cell aging and its implications in therapeutic processes
Sittadjody, S., Ali, A., Thangasamy, T., Akila, M., Kumaran, R., & Opara, E. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820071-1.00010-4 · Cited by 4
Bases moléculaires du vieillissement rénal
Cohen, C. (2021) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2020.02.006 · Cited by 3
Winterhalter, P. R., Wirkner, M., Bartling, B., Wächter, K., Уразова, А. Н., Großkopf, A., Diez, C., Szabo, G. B., & Simm, A. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111635 · Cited by 2
Biologische Alterungsmechanismen im Herz-Kreislauf-System
Großkopf, A., Saemann, L., Szabo, G. B., & Simm, A. (2022) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-022-02094-8 · Cited by 2
“Nichtsdestotrotz konnte gezeigt werden, dass diese Sekretion einen seneszenzauslösenden Einfluss auf benachbarte Zellen haben kann [30].”
BackgroundExtracellular Vesicles and Cardiac Aging
Seara, F. D. A. C., Maciel, L., Kasai-Brunswick, T. H., Nascimento, J. H. M., & de Carvalho, A. C. C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_3 · Cited by 2
Temporal Dynamic Regulation of Autophagy and Senescence Induction in Response to Radiation Exposure
Noguchi, M., Ihara, T., Suzuki, K., & Yokoya, A. (2023) · Radiation Research · doi:10.1667/rade-23-00173.1 · Cited by 2
Mechanisms of cell senescence in aging
von Zglinicki, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00003-2 · Cited by 3
Huang, Q., Wang, Y., Farias, K., Zeng, X., Chen, Q., Cheng, H., Baki, V. B., Gross, S., Geri, J., Sauve, A. A., et al. (2026) · Cardiovascular Research · doi:10.1101/2025.07.15.664959 · Cited by 2
Ismaila, M., Dharmaraj, S., Ong, E. B. B., Tye, G. J., & Sasidharan, S. (2025) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-025-00839-5 · Cited by 1
“Senescent cardiac cells contribute to age-related heart dysfunction, with telomeric damage and fibrosis being key factors (Anderson et al. 2019; Lewis-McDougall et al. 2019).”
Ahmed, B. I., & Konje, J. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124332 · Cited by 1
Emanet, H., DiPietro, F., Philip, S., & Acun, A. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01854-8 · Cited by 1
Mechanisms of aging in the cardiovascular system: challenges and opportunities
Zhao, X., Yang, X., Lin, Y., Lei, R., Ding, W., He, X.-Y., Cao, Y. J., Zhang, D., Liu, P., Liang, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1635736 · Cited by 5
“Many mechanisms that induce cardiomyocyte ageing have been identi fi ed, including telomere shortening (73), epigenetic changes (74), and the SASP (44), but metabolic dysfunction is a key factor contributing to cardiomyocyte ageing and decreased cardiac function (75).”
Wang, L., Dong, X., Yu, L., Jie, H., Wang, B., Li, L., Chen, J., Liu, M., & Dong, B. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025185 · Cited by 2
“This selective enrichment aligns with previous reports showing that senescent cardiomyocytes preferentially secrete profibrotic and prohypertrophic factors such as TGF - β 2 and GDF15 rather than classical inflammatory cytokines [35].”
Senolytic reduction of senescent cells mitigates atrial arrhythmia vulnerability in aging rabbits
Sengun, E., Zhou, L., Kelsey, M. M. G., Turan, N. N., Lu, Y., Kabakov, A. Y., Bronk, P., Mi, E., Kim, T. Y., Vijayakumar, S., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.01.007 · Cited by 1
“33 34-36 These findings parallel the senescence patterns seen in aged rabbit atria, reinforcing the translational relevance of our model and supporting the notion that conserved molecular mechanisms underlie atrial aging across species.”
Wei, Z., Li, Z., & Quan, N. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1702207 · Cited by 1
“For example, SASP from cardiac myocytes can activate cardiac fibroblasts and impair endothelial cell function (Anderson et al., 2019).”
Bou‐Teen, D., Valiuska, S., Miró‐Casas, E., Rubeo, C., Bonzón‐Kulichenko, E., Nichtová, Z., Fernández‐Sanz, C., Inserte, J., Rodríguez‐Sinovas, A., Benito, B., et al. (2026) · Aging Cell · doi:10.1111/acel.70444 · Cited by 2
Bone biology in aging periodontal and peri‐implant tissues
Issa, D. R., Intini, G., & Clark, D. (2026) · Periodontology 2000 · doi:10.1111/prd.70035 · Cited by 2
Cellular senescence as a systems-level driver of cardiovascular ageing
Wang, M.-M., Liu, T., Xu, C.-Q., Zhong, Y.-L., Liang, Z.-Q., Li, J., Cao, Y., & Chen, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103175 · Cited by 4
Yang, P., Yang, Y., Huang, X., Zhu, H., Zhan, Y., Cai, X., Zheng, Z., & Qingshan, T. (2026) · Biology Direct · doi:10.1186/s13062-026-00847-8 · Cited by 1
“Ischemic stress can directly induce stress-induced premature senescence (SIPS) in cardio-myocytes, characterized by upregulation of senescence markers such as p16, p21, and p53, telomere shortening, and disruption of mitochondrial cristae structure [19–22].”
Genomic, epigenomic and transcriptomic regulation of cellular senescence
Salekeen, R., Kieu, T. L., Robbins, P. D., Niedernhofer, L. J., & Laux, L. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00982-y · Cited by 4
Cell senescence is a cause of frailty
Wan, T., Miwa, S., & von Zglinicki, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00013-4 · Cited by 2
Palmer, A. K., & Kirkland, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00012-8 · Cited by 2
Self-citationAin, Q., Schmeer, C. W., Wengerodt, D., Hofmann, Y., Witte, O. W., & Kretz, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063000 · Cited by 2
“Regarding senescence studies, the fingerprints of a senescence-like state in post-mitotic cells including neurons [28,60] are still not confirmed, but might resemble the cellular and molecular features inherent to the process of replicative senescence [29,61].”
BackgroundTo G0 or Not to G0: Cell Cycle Paradox in Senescence and Brain Aging
Ishikawa, S., & Ishikawa, F. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_5 · Cited by 1
Clearance of senescent cells following cardiac ischemia-reperfusion injury improves recoveryPreprint
Dookun, E., Walaszczyk, A., Redgrave, R., Palmowski, P., Tual‐Chalot, S., Suwana, A., Chapman, J., Jirkovský, E., Sosa, L. D., Gill, E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.28.065789 · Cited by 1
“In the absence of MI, aged animals demonstrated an increase in CM renewal following either pharmacogenetic or pharmacological clearance of senescence (12, 42).”
BackgroundMethodInfluentialSelf-citationEstep, K. N., Tobias, J. W., Fernandez, R. J., Beveridge, B. M., & Johnson, F. B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.19.524780 · Cited by 1
Lérida‐Viso, A. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/194709 · Cited by 1
Wang, L., Deng, Z., Li, Y., Wu, Y., Yao, R.-Q., Cao, Y., Wang, M., Zhou, F., Zhu, H., & Kang, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3318999/v1 · Cited by 1
Genetics of Cardiac Aging Implicate Organ-Specific VariationPreprint
Brundage, J., Barrios, J. P., Tison, G. H., & Pirruccello, J. P. (2024) · medRxiv · doi:10.1101/2024.08.02.24310874 · Cited by 2
Bouhrira, N., Pizarro, S., Senf, V., & Margulies, K. B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.17.665449 · Cited by 2
Molecular Mechanisms of Cardiomyocyte AgingPreprint
Yücel, D., Trembley, M. A., Ke, Q., Wu, Z., Kang, P. M., & Pu, W. T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.29.666777 · Cited by 1
“At an earlier timepoint, a prior study demonstrated that length-independent telomere damage may play a significant role in cardiac aging and precede telomere shortening 23 .”
Redgrave, R. E., Booth, L. K., & Richardson, G. D. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf220 · Cited by 1
Self-citationStochastic Nature of Cellular Aging: The Role of Telomeres
Vidaček, N. Š., & Rubelj, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11457-6
Discovery of Senolytics and the Pathway to Early Phase Clinical Trials
Gerdes, E. O. W., Zhu, Y. Z., Tchkonia, T., & Kirkland, J. L. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_2
Self-citationMitochondria: Potential Targets for Interventions to Counteract Senescence
Lagnado, A. B., Victorelli, S. G., & Passos, J. F. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_11
Self-citationDookun, E. (2020)
Self-citationGomez-Cid, L., Moro-López, M., Nava, A., Fernandez, A. I., Fernández‐Santos, M. E., Atienza, F., Grigorian, L., & Fernández‐Avilés, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab724.3317
The Quest for a Biomarker of Premature Biological Aging
Thorin, É., & Thorin‐Trescases, N. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.11.012
Chiao, Y. A., Dai, D., Wessells, R. J., & Rabinovitch, P. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00015-9
Kartha, C. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-85536-9_12
Kravchenko, K., Kozlov, K. L., Дробинцева, А. О., Медведев, Д. С., & Polyakova, V. O. (2022) · Advances in Gerontology · doi:10.1134/s2079057022020126
Cellular senescence and other aging mechanisms in bone and muscle
Kaur, J., & Farr, J. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820088-9.00008-1
Ishaq, A., & Saretzki, G. C. (2022) · Recent Progress in Nutrition · doi:10.21926/rpn.2203016
Cellular senescence during aging
von Zglinicki, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00017-3 · Cited by 1
Telomeres and cell homeostasis in aging
Victorelli, S. G., & Passos, J. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00029-x
Self-citationHalmos, T., & Suba, I. (2023) · Magyar Tudomány · doi:10.1556/2065.184.2023.7.7 · Cited by 2
Takenaka, Y., Hirasaki, M., Inoue, I., Ikeda, M., Ohata, H., & Kakinuma, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.20.554007 · Cited by 1
Chen, L., Zhao, Y., Chen, H., Tan, T., Yao, P., & Tang, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-961620/v1
Wijaya, M. H., Ghanie, A., Riviati, N., & Saleh, M. I. (2023) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.37275/bsm.v7i10.879
Unlocking the dark matter: noncoding RNAs and RNA modifications in cardiac aging
Kang, J., Rhee, J., Wang, C., Yang, Y., Li, G., & Li, H. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00532.2023
Age-related disease: Cardiovascular system
Nilsson, P. M., Fossel, M., Bean, J., & Khera, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00010-4 · Cited by 2
Anti-aging effect of TRF2 inhibition in skeletal myofibersPreprint
Burbano, M. S. J., Robin, J. D., Martin, M., Gondin, J., Pousse, M., Thomas, J.-L., Bauwens, S., Girard, E., del Carmine, P., Belotti, E., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4187702/v1
Growth and proliferation of cardiomyocytes
Duttaroy, A. K., & Mallick, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99570-2.00018-7
Identification of cardiac premature senescence markers through GEO database interaction approach
Susantiningsih, T., Prijanti, A. R., Hardiany, N. S., & Fadilah, F. (2024) · Acta Biochimica Indonesiana · doi:10.32889/actabioina.110
Aging and rejuvenation of engineered cardiovascular tissues: from research to clinical application
Liu, C. X., Guo, J., Zhang, Y., Hu, M., Hao, T., Crețoiu, D., Li, G., & Xiao, J. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.11 · Cited by 1
Wang, Y. (2024) · Aging Research · doi:10.26599/agr.2024.9340031
Association Analysis of Telomere Length and Vision in a Large Community-Based Survey
Zhang, B., & Zhao, Y. (2024) · Ophthalmic Epidemiology · doi:10.1080/09286586.2024.2422349
“31,32 These mechanisms, rather than telomere shortening, may play an important role in vision senescence, which could be addressed in future studies.”
The role of cardiovascular aging in heart failure
Greco, D., & Boakye‐Yiadom, K. O. (2025) · doi:10.32948/ajsep.2025.01.10
Cellular Senescence and Cardiovascular Aging
Kapoor, D., & Qamar, I. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_9
Schneider, S. E., Scott, A. K., Gallagher, K. M., Miller, E. Y., Ghosh, S., & Neu, C. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.16.643588
Recent Advances in the Study of Biomarkers of Aging
肖, 夤. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153869
Aging-related comorbidities, life-style interventions and therapeutic strategies in heart failure
Phan, N. N., & Yunus, F.-U.-N. (2025) · doi:10.32948/ajsep.2025.03.20
SENESCENT CELLS AND THEIR IMPORTANCE IN HISTOGENESIS
Deev, R. V., Markina, Y. V., Kirichenko, T. V., Zhivodernikov, I. V., Markin, A. M., Eremin, I. I., & Kotenko, K. V. (2025) · Morphology · doi:10.17816/morph.677025
Monteiro, L. M., Pitrez, P. R., Correia-Santos, S., Dark, N., Santinha, D. R., Aveleira, C. A., Townsend, M., Taylor, J., Nissan, X., Sardão, V. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.27.661680
ULK1 phosphorylation and cardiomyocyte senescence: molecular nexus in cardiac ageing
Vinci, M. C. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf132
Telomere 3’-overhang attrition and persistent telomeric DNA damage response in failing human heartsPreprint
Ye, B., Shang, L., Yuan, X., Xu, Y., Wen, Y., Shi, Y., Xu, H., Wang, X., Margulies, K. B., Wang, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.12.669993
“This suggests that telomere dysfunction can be independent of total TL, consistent with findings reported in both post-mitotic CMs 40 and proliferation-competent cells.”
Ragusa, F. S., Veronese, N., D’Aleo, A., et al. (2025) · European Journal of Translational Myology · doi:10.4081/ejtm.2025.13940
Endothelial expression of ZBTB16 protects against cardiac agingPreprint
Stilz, K. A., Leonard, V. E., Morales, D. R., Glaser, S.-F., Larcher, V., Jurado, M. R., Malacarne, P. F., Manickam, N., Tombor, L. S., Abplanalp, W. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.08.681100
“Likewise, senolytic treatments, which remove senescent cells, show promising benefits in cardiovascular disease models 5 – 10 .”
Orlova, E. A., Abdyev, V. K., Morgunova, V., Schukina, A., Кунгурцева, А. Л., Vasiluev, P. A., Tabakov, V. Y., Vorontsova, E. О., Zinina, E., Izvolskaia, M. S., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10333-9 · Cited by 1
“Telomere-associated γH2AX foci or telomere-induced foci (TIF) reflect dysfunctional telomere status (Takai et al. 2003) and accumulate in the tissues irrespectively of telomere length during normal aging (Fumagalli et al. 2012; Hewitt et al. 2012; Anderson et al. 2019).”
Aging-driven organelle miscommunication in the failing heart
Ortega, A., Bascuñan-Ortiz, E., Troncoso, M. F., Muñoz-Rodríguez, C., Navarrete-Gallegos, L., Yero-Haber, R., Becerra, B., Mora, A., Lopez‐Gallardo, E., Chiong, M., et al. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2025.08 · Cited by 1
Sharma, R. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152881 · Cited by 2
Role of Vascular Niche in Cardiac Aging
Ikeda, S., Sung, E., & Sadoshima, J. (2025) · Circulation Research · doi:10.1161/circresaha.125.327363
Wang, M., Liu, L., Liu, Y., Zhao, Y., & Yu, S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01911-9
“In the context of IR injury, a hallmark feature of cellular senescence is the formation of telomere-associated DNA damage foci (TAF), which have been experimentally validated to be induced by oxidative stress [40].”
Cellular Senescence in Heart Failure: A Review
Krauz, K., Czarzasta, K., Bugajewski, M., Momot, K., Wojciechowska, M., & Cudnoch‐Jędrzejewska, A. (2026) · Journal of Cellular Physiology · doi:10.1002/jcp.70136 · Cited by 2
“This state involves activation of traditional senescence pathways and secretion of SASP which composition is not typical (Anderson et al. 2019).”
Ikeda, M., Tanaka, Y., Sugihara, H., Matsuwaki, T., & Yamanouchi, K. (2026) · The FASEB Journal · doi:10.1096/fj.202500098r
Myocardial Aging: Cellular Mechanisms and Therapeutic Perspectives
Filatova, T. S., Dzhumaniiazova, I., Shamshura, A. V., & Abramochkin, D. V. (2026) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093026010151
“Apparently, ROS generation leads to telomere and genome damage, resulting in the accu(cid:2) mulation of senescent cardiomyocytes in the heart with age [168].”
Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases
Liu, R.-M., & Nakamya, M. F. (2026) · Cells · doi:10.3390/cells15060551 · Cited by 1
“In transverse aortic constriction (TAC) and isoproterenol-induced heart failure mouse models, senescent cardiomyocytes exhibit hypertrophy, mitochondrial dysfunction, and TGF-β -rich SASP secretion [201,202].”
Type 2 Diabetes From the Perspective of Telomere Biology
Cao, H., Feng, H., Shen, Z., & Huang, Y. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70137
Impact of aging on cardiac mesenchymal stromal cells
Martini, H. (2019) · theses.fr (ABES) · doi:10.70675/bb7ddcb3z0b6az4c39za6eczc94e0563f0a3
Intermittent hypoxia induces premature adipose tissue senescence leading to cardiac remodelling
Naushad, S. (2022) · theses.fr (ABES) · doi:10.70675/8490fe58zf0fdz45a9zaa53z703053f519c1
Caffeic acid ameliorates D-galactose-induced brain senescence via the BHMT/NMDAR/CREB axis
Ni, H., Liao, Y., Lai, Y., Gao, L., Ke, H., Zhuo, Y., Zhou, R., He, Q., Wang, Q., Ning, W., et al. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107292
Cell-specific vulnerabilities and adaptations in atrial aging
Braun, A. M. T., Lang, A., & Wagner, J. U. G. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag081
Targets of senescence in cardiac muscle: insights for regenerative treatments in the aged heart
Ellison, G. M., & Torella, D. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671690
“…senolytics (Navitoclax, D +Q) or genetic (using INK-ATTAC+AP mice) clearance of senescent cells in aged mice alleviated the detrimental features of cardiac aging, including myocardial dysfunction, hypertrophy and fibrosis, and induced a compensatory cardiomyocyte renewal and replacement [18–20].”
Multicellular senescence programs in the aged heart
Bultot, L., Tsurudome, N., Kumazaki, E., & Shimizu, I. (2026) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2026.100852
“…accumulate telomere-associated DNA damage foci independently of telomere length, producing a pro-fibrotic and hypertrophic SASP; genetic or pharmacological senolysis reverses hypertrophy and fibrosis in the aging myocardium, suggesting potential translational relevance of these biomarkers [40].”
InfluentialProkopov, A., Дробинцева, А. О., Любякина, П. Н., & Kvetnoy, I. M. (2026) · Успехи геронтологии · doi:10.34922/ae.2026.39s
Shao, Q., Chen, D., Shao, W., & Ye, Q. (2026) · Research · doi:10.34133/research.1326 · Cited by 1
“…by persistent insult, hallmarked by pathological accumulation of extracellular matrix components, and constitutes a central pathological outcome across diverse aging-associated disorders, such as CKD [ 104 , 105 ], cardiac fibrosis and heart failure [ 106 ], and pulmonary fibrosis [ 107 ].”
Biology of Telomeres and Telomerase in Ageing
Saretzki, G. C. (2026) · Wiley eBooks · doi:10.1002/9780470015902.a0029951
Huang, W., Kong, B. Z., Zhong, Y., Xu, J., Wu, J., Wang, Y., Wang, H., Hu, H., Yao, Z., Shen, Y., et al. (2026) · Hearing Research · doi:10.1016/j.heares.2026.109691
Metadata
- Authors
- Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., Proctor, C., Correia‐Melo, C., Victorelli, S., Fielder, E., Berlinguer‐Palmini, R., Owens, A., Greaves, L. C., Kolsky, K. L., Parini, A., Douin‐Echinard, V., LeBrasseur, N. K., Arthur, H. M., Tual‐Chalot, S., Schafer, M. J., Roos, C. M., Miller, J. D., Robertson, N., Mann, J., Adams, P. D., Tchkonia, T., Kirkland, J. L., Mialet‐Perez, J., Richardson, G. D., & Passos, J. F.
- Affiliations
- Newcastle University (GB)
- Inserm (FR)
- Mayo Clinic (US)
- Wellcome Centre for Mitochondrial Research (GB)
- Cancer Research UK Scotland Institute (GB)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- ORCID
- Lagnado, Anthony
- Maggiorani, Damien
- Walaszczyk, Anna
- Dookun, Emily
- Chapman, James
- Birch, Jodie
- Salmonowicz, Hanna
- Ogrodnik, Mikolaj
- Jurk, Diana
- Proctor, Carole
- Correia‐Melo, Clara
- Victorelli, Stella
- Fielder, Edward
- Berlinguer‐Palmini, Rolando
- Greaves, Laura C
- Parini, Angelo
- Douin‐Echinard, Victorine
- LeBrasseur, Nathan K
- Arthur, Helen M
- Tual‐Chalot, Simon
- Schafer, Marissa J
- Miller, Jordan D
- Robertson, Neil
- Mann, Jelena
- Adams, Peter D
- Kirkland, James L
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- Venue
- The EMBO Journal
- Published
- 2019-02-08
- Volume
- 38
- Issue
- 5
- Pages
- e100492
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC6396144
- OpenAlex
- W2913284769
- Semantic Scholar
- f2b575f4b8dabea90337c591a95d86658c57701d
- Cited by
- 532
- References
- 60
- Citations by year
- 2026: 59 · 2025: 80 · 2024: 83 · 2023: 68 · 2022: 77 · 2021: 70 · 2020: 67 · 2019: 28
- FWCI
- 41.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Connor Group
- Noaber Foundation
- Région Occitanie, France
- Medical Research Council and Arthritis UK funded centre for integrated Musculoskeletal Ageing (MR/K0063121/1)
- RCUK | Biotechnology and Biological Sciences Research Council (BB/H022384/1, BB/K017314/1)
- British Heart Foundation (PG/15/85/31744)
- Foundation for the National Institutes of Health (AG013925)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- cardiomyocyte senescence, cellular senescence, cardiac aging, senolytics, senescence-associated secretory phenotype, p21, p16INK4a, mitochondrial dysfunction, myocardial fibrosis, cardiac hypertrophy, age-related cardiac dysfunction
- MeSH terms
- Aging, Animals, DNA Damage, Female, Fibrosis, Cardiomegaly, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mitosis, Monoamine Oxidase, Phenotype, RNA, Cellular Senescence, Rats, Sprague-Dawley, Mice, Knockout, Telomerase, Myocytes, Cardiac, Mice, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.